RHB stated in a research note on Thursday that RAFFLES Medical’s near-term earnings will likely benefit from loosening restrictions and efforts to reopen Singapore’s borders./n
Read MoreBrokers’ take: RHB raises Raffles Medical’s target price to S$1.35 on Singapore’s reopening plans
2021-07-08T04:42:31-04:00July 8th, 2021|
Related Posts
-
US dollar mostly flat as market mulls inflation outlook
May 19th, 2024 -
Didi’s Liu giving up roles as president, board director
May 19th, 2024 -
Lamborghini CEO sees fully electric supercars a ways off
May 19th, 2024